Autoimmune diseases, immune modulation, inflammation, and self-tolerance
203 articles
Chinese researchers test safer alternative to CAR-T therapy for lupus patients, achieving remission in 67% with minimal side effects.
New analysis reveals comparable effectiveness between JAK inhibitors and biological therapies for rheumatoid arthritis patients.
Study reveals how specific antibodies affect tolerance to different rheumatoid arthritis medications, offering personalized treatment insights.
FIRST-RA study follows 300 patients to measure early pain relief and functional improvements with filgotinib treatment.
Advanced lung biopsy technique uncovers serious pneumonia complications from methotrexate treatment in rheumatoid arthritis patients.
Advanced genetic analysis reveals new pathways to personalized RA therapy, addressing treatment failures in 30-40% of patients.
Study of 61 RA patients reveals 85% satisfaction with knee replacement, with quality of life improvements predicting success better than clinical measures.
New study reveals how 2023 drug safety warnings led to less effective treatment choices for rheumatoid arthritis patients.
Systematic review of 87 clinical trials reveals JAK inhibitors offer targeted therapy for rheumatoid arthritis with distinct safety profiles.
New research reveals how the immune system's own antibodies trigger diversification, creating broader protection against pathogens.
New research reveals how our antibodies develop sophisticated defenses against harmful bacteria through repeated childhood infections.
New research reveals how our antibody responses against harmful bacteria mature and strengthen through repeated exposure over time.
